Bradenton bioscience company invests in 3D printing technology business


  • Manatee-Sarasota
  • Share

A Bradenton company that develops advanced drug delivery technologies for complex and chronic diseases has made a strategic investment in a 3D-printed microneedle technology. Continuity Biosciences LLC did not disclose the amount it invested into PinPrint Inc.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content